Understanding Latent Tuberculosis: A Moving Target

被引：335
作者：
Lin, Philana Ling [2 ]
Flynn, JoAnne L. [1 ]
机构：
[1] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Dept Pediat, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15224 USA
来源：
JOURNAL OF IMMUNOLOGY | 2010年 / 185卷 / 01期
基金：
美国国家卫生研究院;
关键词：
TUMOR-NECROSIS-FACTOR; HUMAN-IMMUNODEFICIENCY-VIRUS; NITRIC-OXIDE SYNTHASE; CD8(+) T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; IMMUNE-RESPONSES;
D O I：
10.4049/jimmunol.0903856
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Tuberculosis (TB) remains a threat to the health of people worldwide. Infection with Mycobacterium tuberculosis can result in active TB or, more commonly, latent infection. Latently infected persons, of which there are estimated to be similar to 2 billion in the world, represent an enormous reservoir of potential reactivation TB, which can spread to other people. The immunology of TB is complex and multifaceted. Identifying the immune mechanisms that lead to control of initial infection and prevent reactivation of latent infection is crucial to combating this disease. The Journal of Immunology, 2010, 185: 15-22.
引用
收藏
页码：15 / 22
页数：8
相关论文
共 123 条
  • [1] Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical status
    Abebe, Markos
    Doherty, T. Mark
    Wassie, Liya
    Aseffa, Abraham
    Bobosha, Kidist
    Demissie, Abebech
    Zewdie, Martha
    Engers, Howard
    Andersen, Peter
    Kim, Louise
    Huggett, Jim
    Rook, Graham
    Yamuah, Lawrence K.
    Zumla, Alimuddin
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (01) : 291 - 301
  • [2] Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice
    Abel, B
    Thieblemon, N
    Quesniaux, VJF
    Brown, N
    Mpagi, J
    Miyake, K
    Bihl, F
    Ryffel, B
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (06) : 3155 - 3162
  • [3] Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994
  • [4] Influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during mycobacterium tuberculosis infection
    Algood, HMS
    Lin, PL
    Yankura, D
    Jones, A
    Chan, J
    Flynn, JL
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (11) : 6846 - 6857
  • [5] Amukotuwa Shalini, 2005, Int Semin Surg Oncol, V2, P10, DOI 10.1186/1477-7800-2-10
  • [6] [Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_
  • [7] Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts
    Arend, Sandra M.
    Thijsen, Steven F. T.
    Leyten, Eliane M. S.
    Bouwman, John J. M.
    Franken, Willeke P. J.
    Koster, Ben F. P. J.
    Cobelens, Frank G. J.
    van Houte, Arend-Jan
    Bossink, Ailko W. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (06) : 618 - 627
  • [8] Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study
    Badri, M
    Wilson, D
    Wood, R
    [J]. LANCET, 2002, 359 (9323) : 2059 - 2064
  • [9] TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis
    Bafica, A
    Scanga, CA
    Feng, CG
    Leifer, C
    Cheever, A
    Sher, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12) : 1715 - 1724
  • [10] Tuberculosis transmission in central Los Angeles
    Barnes, PF
    Yang, ZH
    PrestonMartin, S
    Pogoda, JM
    Jones, BE
    Otaya, M
    Eisenach, KD
    Knowles, L
    Harvey, S
    Cave, MD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (14): : 1159 - 1163
12345678910